Medinotec (MDNC) Liabilities and Shareholders Equity (2022 - 2026)

Medinotec's Liabilities and Shareholders Equity history runs 5 years deep, the most recent figure standing at $7.0 million for Q2 2026.

• Quarterly Liabilities and Shareholders Equity fell 5.66% year-over-year to $7.0 million in Q2 2026, while the trailing twelve-month figure through May 2026 was $27.0 million (up 8.65% YoY) and the FY2026 annual result came in at $6.8 million, changed 0.06% from the prior year.
• Liabilities and Shareholders Equity was $7.0 million for Q2 2026 at Medinotec, up from $6.8 million in the prior quarter.
• Across five years, Liabilities and Shareholders Equity topped out at $7.4 million in Q2 2025 and bottomed at $1.3 million in Q1 2022.
• A 5-year average of $5.3 million and a median of $5.2 million in 2022 frame the typical range for Liabilities and Shareholders Equity.
• Peak annual rise in Liabilities and Shareholders Equity reached 239.4% in 2023, while the deepest fall reached 21.61% in 2023.
• Medinotec's Liabilities and Shareholders Equity stood at $5.1 million in 2022, then declined by 21.61% to $4.0 million in 2023, then jumped by 34.34% to $5.4 million in 2024, then climbed by 27.79% to $6.9 million in 2025, then rose by 1.93% to $7.0 million in 2026.
• Business Quant data shows MDNC's Liabilities and Shareholders Equity at $7.0 million in Q2 2026, $6.8 million in Q1 2026, and $6.9 million in Q4 2025.